To sum up, T-DM1 is a relatively safe and effective agent in the treatment of advanced or metastatic HER2-positive breast cancer, even among patients with asymptomatic or treated brain metastases and trastuzumab resistance14, 15, 16, 25, 27, 34, 35, 36, 37. The gene discussed is ERBB2; the disease is breast cancer.